22-Year Biotech Veteran Shares Best Stock-Picking Tips

"The biotech sector produces gains that would make a tech investor jealous!" ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

AN OXFORD CLUB PUBLICATION

View in browser SPONSORED Could Elon Musk's New Project Be Worth Trillions of Dollars? Elon Musk has predicted that his new venture "X-9840" could be "a multi trillion dollar company..." As big as Microsoft... Apple... and Nvidia... Companies gave their early investors a chance to become millionaires over the long term, starting with just $1,000. Click here to see the details because this has nothing to do with electric vehicles... self-driving cars, rockets, brain chips, or satellites. MARKET TRENDS Marc's Checklist for Uncovering Biotech Winners James Ogletree, Managing Editor, The Oxford Club According to one of the leading voices on investing in biotech, "The biotech sector produces gains that would make a tech investor jealous. These stocks can absolutely launch when they receive positive news." Who is that expert, you ask? SPONSORED Yours Free! Top FIVE Dividend Stocks Right Now Marc Lichtenfeld - income expert and author of Get Rich with Dividends - is giving away his Ultimate Dividend Package... completely free of charge! You'll discover... An "A"-rated, ultra-safe dividend stock with a huge 8% yield Three of Marc's favorite "Extreme Dividend" stocks, which could supercharge your income And finally, Marc's No. 1 dividend stock for a LIFETIME of income. Click here to get the names and ticker symbols now... before the download link expires. **NO CREDIT CARD REQUIRED!** Our very own Chief Income Strategist Marc Lichtenfeld! Having studied biotech for over two decades, Marc has more knowledge of the inner workings of the sector than almost anyone else. And in this episode of State of the Market from last August, he goes over the three items on his checklist for uncovering winning stocks in the biotech sector. Watch the Episode Here Good investing, James P.S. Did you miss Marc's live broadcast on Thursday afternoon? During this special event, he discussed how one up-and-coming biotech company could spark an enormous "AI Biotech Revolution." This company checks all three boxes on Marc's checklist for winning biotech stocks. To learn more about the AI Biotech Revolution and find out how to get the name and ticker of Marc's favorite biotech stock today, click here to watch the recording of Thursday's broadcast. BUILD AND PROTECT YOUR WEALTH New IPO Signs MAJOR Deal with Apple Until 2040. Will It Be the Next Trillion Dollar Company? Are These Seven Stocks Still Magnificent? Get Marc's Top 5 Dividend Stocks (FREE PICKS) The Sweet Spot to Invest in the Biotech Sector MORE FROM WEALTHY RETIREMENT The Top 3 Criteria for Uncovering Biotech Winners Dorchester Minerals: An Oil Field Landlord Trading at a Discount? Is Xerox's 7% Yield as Shaky as Its Stock? Earn Income While Playing the Hottest Sectors Facebook LinkedIn Email Share Push Alert SPONSORED These 3 Cryptos Could All Be Bigger Than Bitcoin Yet each is trading for a tiny fraction of what Bitcoin and Ethereum cost. Now top crypto traders are pouring in... Find out why here. You are receiving this email because you subscribed to Wealthy Retirement. Wealthy Retirement is published by The Oxford Club. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. Privacy Policy | Whitelist Wealthy Retirement | Unsubscribe © 2024 The Oxford Club, LLC All Rights Reserved The Oxford Club | 105 West Monument Street | Baltimore, MD 21201 North America: 877.808.9795 | International: +1.443.353.4621 Oxfordclub.com Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201.